SEC EDGAR: material events, stakes, listings, share offerings, annual and quarterly reports.
Showing Thursday 13 August 2026. Back to the latest
Thursday 13 August 2026
1,464 records- 8-K
Pelthos Therapeutics Inc. says earlier financial statements can no longer be relied on
Form 8-K, item 4.02.
- 8-K
Pelthos Therapeutics Inc. says earlier financial statements can no longer be relied on
Form 8-K, items 2.02, 4.02, 7.01. Also published results; made a Regulation FD disclosure.
- 8-K
Nocera, Inc. received a delisting or listing-standard notice
Form 8-K, items 2.01, 3.01. Also completed an acquisition or disposal.
- 8-K
BlackSky Technology Inc. received a delisting or listing-standard notice
Form 8-K, item 3.01.
- Delisting
Nyse Arca, Inc. filed to remove Janus Detroit Street Trust from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Babcock & Wilcox Enterprises, Inc. from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
Nasdaq Stock Market LLC filed to remove AEye, Inc. from listing
Form 25-NSE, notice of removal from listing and registration.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming BlossomHill Therapeutics, Inc. and Cormorant Asset Management, LP.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Marpai, Inc. and Mitchell Calvin Steven.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming EWSB Bancorp, Inc. /MD/ and Spence Limited, LP.
- 8-K
Vireo Growth Inc. completed an acquisition or disposal
Form 8-K, items 1.01, 2.01. Also entered a material agreement.
- 8-K
Global Net Lease, Inc. completed an acquisition or disposal
Form 8-K, items 2.01, 3.02, 7.01. Also sold shares without registration; made a Regulation FD disclosure.
- 8-K
Parker-Hannifin Corp completed an acquisition or disposal
Form 8-K, items 2.01, 2.03. Also took on a new financial obligation.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming HeartBeam, Inc. and Strome Mark E.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming BlackRock ESG Capital Allocation Term Trust and Saba Capital Management, L.P.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Ardagh Group S.A. and Ardagh Metal Packaging S.A.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Evogene Ltd. and Recanati Leon.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Ignition Acquisition Holdings GP LLC and OPENLANE, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Marpai, Inc. and Mitchell Calvin Steven.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming HHCF Series 21 Sub, LLC and Katapult Holdings, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming ONE Group Hospitality, Inc. and Segal Jonathan.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Huang Ximing and Sharing Economy International Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Equinox Partners Investment Management LLC and Gran Tierra Energy Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Matinas BioPharma Holdings, Inc. and Sanitam Partners LLC.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Griffiths Richard Ian and Silence Therapeutics plc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming USA Compression Partners, LP and Westerman Interests, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Mas Jorge and Mastec Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Mas Jose Ramon and Mastec Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Appfolio Inc and Duca Maurice J.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Indivior Pharmaceuticals, Inc. and Oaktree Capital Holdings, LLC.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming BOSTON OMAHA Corp and Sky Harbour Group Corp.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Evogene Ltd. and L.I.A. Pure Capital Ltd.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Allient Inc and Juniper Investment Company, LLC.
- 8-K
Silexion Therapeutics Corp entered a material agreement
Form 8-K, items 1.01, 8.01. Also reported other events.
- 8-K
Sino Green Land Corp. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Illumina, Inc. entered a material agreement
Form 8-K, items 1.01, 1.02, 2.03. Also ended a material agreement; took on a new financial obligation.
- 8-K
Sonida Senior Living, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Professional Diversity Network, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Eureka Acquisition Corp entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02. Also took on a new financial obligation; sold shares without registration.
- 8-K
Life Time Group Holdings, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Lithium Americas Corp. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02. Also took on a new financial obligation; sold shares without registration.
- 8-K
Tempest Therapeutics, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
WABASH NATIONAL Corp entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
MapLight Therapeutics, Inc. entered a material agreement
Form 8-K, items 1.01, 2.02. Also published results.
- 8-K
Universal Health Services Inc entered a material agreement
Form 8-K, item 1.01.
- 8-K
Vestand Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Nauticus Robotics, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
ONE Gas, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Southland Holdings, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
NEWMONT Corp /DE/ entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
TWFG, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03, 7.01. Also took on a new financial obligation; made a Regulation FD disclosure.
- 8-K
Veea Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Opendoor Technologies Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Cloudflare, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Digital Asset Acquisition Corp. entered a material agreement
Form 8-K, items 1.01, 1.02, 8.01. Also ended a material agreement; reported other events.
- 8-K
Aptevo Therapeutics Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Magnolia Bancorp, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
GrabAGun Digital Holdings Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Evolution Metals & Technologies Corp. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Xylem Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Starwood Property Trust, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Widepoint Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Zenas BioPharma, Inc. reports a director or officer change
Form 8-K, items 2.02, 5.02. Also published results.
- 8-K
Sprinklr, Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
OFA Group reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Internet Sciences Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Marqeta, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Omeros Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
iRhythm Holdings, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Marqeta, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Teladoc Health, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
SCI Engineered Materials, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
OnKure Therapeutics, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Olema Pharmaceuticals, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Bank of New York Mellon Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Federal Home Loan Bank of Cincinnati took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Chicago took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
TuHURA Biosciences, Inc./NV took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Des Moines took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Dallas took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Boston took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Topeka took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of San Francisco took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Pittsburgh took on a new financial obligation
Form 8-K, item 2.03.
- Offering
BayFirst Financial Corp. filed to register new shares
Form S-1, registration statement.
- 8-K
Granite Construction Inc sold shares without registration
Form 8-K, items 3.02, 8.01. Also reported other events.
- 8-K
Liberty Media Corp sold shares without registration
Form 8-K, items 3.02, 7.01, 8.01. Also made a Regulation FD disclosure; reported other events.
- 8-K
Kustom Entertainment, Inc. sold shares without registration
Form 8-K, item 3.02.
- 8-K
Healthy Choice Wellness Corp. sold shares without registration
Form 8-K, item 3.02.
- 8-K
Vivakor, Inc. sold shares without registration
Form 8-K, items 3.02, 7.01. Also made a Regulation FD disclosure.
- Offering
Professional Diversity Network, Inc. published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
Thunder Bridge Capital Partners V, Ltd. published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
Silexion Therapeutics Corp published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
SunScout Holding Ltd published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
Curis Inc published a final prospectus
Form 424B4, prospectus for a priced offering.
- 8-K
Tri Pointe Homes, Inc. published results
Form 8-K, item 2.02.
- 8-K
Ondas Inc. published results
Form 8-K, item 2.02.
- 8-K
Odysight.ai Inc. published results
Form 8-K, item 2.02.
- 8-K
Gossamer Bio, Inc. published results
Form 8-K, item 2.02.
- 8-K
Nektar Therapeutics published results
Form 8-K, item 2.02.
- 8-K
Sensus Healthcare, Inc. published results
Form 8-K, item 2.02.
- 8-K
MiNK Therapeutics, Inc. published results
Form 8-K, item 2.02.
- 8-K
Instil Bio, Inc. published results
Form 8-K, item 2.02.
- 8-K
HeartCore Enterprises, Inc. published results
Form 8-K, item 2.02.
- 8-K
Tenon Medical, Inc. published results
Form 8-K, item 2.02.
- 8-K
Vivani Medical, Inc. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Veritone, Inc. published results
Form 8-K, item 2.02.
- 8-K
KULR Technology Group, Inc. published results
Form 8-K, item 2.02.
- 8-K
Ideal Power Inc. published results
Form 8-K, item 2.02.
- 8-K
SBC Medical Group Holdings Inc published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
International Battery Metals Ltd. published results
Form 8-K, item 2.02.
- 8-K
Oxbridge RE Holdings Ltd published results
Form 8-K, item 2.02.
- 8-K
Figure Technology Solutions, Inc. published results
Form 8-K, item 2.02.
- 8-K
Nextnrg, Inc. published results
Form 8-K, item 2.02.
- 8-K
QXO, Inc. published results
Form 8-K, item 2.02.
- 8-K
Petmed Express Inc published results
Form 8-K, item 2.02.
- 8-K
Elutia Inc. published results
Form 8-K, item 2.02.
- 8-K
Karyopharm Therapeutics Inc. published results
Form 8-K, item 2.02.
- 8-K
Mobix Labs, Inc published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Pulmatrix, Inc. published results
Form 8-K, item 2.02.
- 8-K
Kodiak Sciences Inc. published results
Form 8-K, item 2.02.
- 8-K
Techprecision Corp published results
Form 8-K, item 2.02.
- 8-K
Solo Brands, Inc. published results
Form 8-K, item 2.02.
- 8-K
Midera Food Processing, Inc. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Fitlife Brands, Inc. published results
Form 8-K, items 2.02, 5.07, 7.01. Also reported shareholder vote results; made a Regulation FD disclosure.
- 8-K
Soluna Holdings, Inc published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Wolverine World Wide Inc /DE/ published results
Form 8-K, item 2.02.
- 8-K
Rockwell Medical, Inc. published results
Form 8-K, item 2.02.
- 8-K
Immucell Corp /DE/ published results
Form 8-K, item 2.02.
- 8-K
enCore Energy Corp. published results
Form 8-K, item 2.02.
- 8-K
LENSAR, Inc. published results
Form 8-K, item 2.02.
- 8-K
Horizon Kinetics Holding Corp published results
Form 8-K, item 2.02.
- 8-K
Madison Square Garden Sports Corp. published results
Form 8-K, item 2.02.
- 8-K
Rani Therapeutics Holdings, Inc. published results
Form 8-K, item 2.02.
- 8-K
Jefferson Capital, Inc. / DE published results
Form 8-K, item 2.02.
- 8-K
Invivyd, Inc. published results
Form 8-K, item 2.02.
- 8-K
Live Ventures Inc published results
Form 8-K, item 2.02.
- 8-K
Elmet Group Co. published results
Form 8-K, item 2.02.
- 8-K
Quantum-Si Inc published results
Form 8-K, item 2.02.
- 8-K
YETI Holdings, Inc. published results
Form 8-K, item 2.02.
- 8-K
Fate Therapeutics Inc published results
Form 8-K, item 2.02.
- 8-K
Parabilis Medicines, Inc. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
SOLV Energy, Inc. published results
Form 8-K, item 2.02.
- 8-K
Global Water Resources, Inc. published results
Form 8-K, item 2.02.
- 8-K
Eton Pharmaceuticals, Inc. published results
Form 8-K, item 2.02.
- 8-K
Intuitive Machines, Inc. published results
Form 8-K, item 2.02.
- 8-K
Ovid Therapeutics Inc. published results
Form 8-K, item 2.02.
- 8-K
Legence Corp. published results
Form 8-K, item 2.02.
- 8-K
PDS Biotechnology Corp published results
Form 8-K, item 2.02.
- 8-K
Merlin, Inc. published results
Form 8-K, item 2.02.
- Insider trades
464 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Consumer Portfolio Services, Inc. (14), First National Corp /VA/ (11), Applied Industrial Technologies Inc (8), Qorvo, Inc. (8), Fortinet, Inc. (7), Hadron Energy, Inc. (7).
SEC Form 4
Showing the 150 most material of 1,000.